 MALVERN, Pa., April 19, 2022 GLOBE NEWSWIRE -- Ocugen, Inc. NASDAQ: OCGN, a biotechnology company focused on discovering, developing, and commercializing novel gene therapies, biologicals and vaccines, today announces that Dr. Shankar Musunuri, Chairman, CEO and Co-Founder of Ocugen, will present on-location at NobleCon18 - Noble Capital Markets Eighteenth Annual Investor Conference. 